Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period endedMay 31, 2005
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 0-11488
PENFORD CORPORATION
Washington | 91-1221360 | |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
7094 South Revere Parkway, Centennial, Colorado | 80112-3932 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code:(303) 649-1900
Former Address: 7094 South Revere Parkway, Englewood, Colorado 80112-3932
Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yesþ Noo
Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yesþ Noo
The net number of shares of the Registrant’s common stock (the Registrant’s only outstanding class of stock) outstanding as of July 7, 2005 was 8,825,133.
Table of Contents
PENFORD CORPORATION AND SUBSIDIARIES
INDEX
Page | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6 | ||||||||
13 | ||||||||
19 | ||||||||
19 | ||||||||
20 | ||||||||
21 | ||||||||
Certification of CEO Pursuant to Section 302 | ||||||||
Certification of CFO Pursuant to Section 302 | ||||||||
Certification of CEO & CFO Pursuant to Section 906 |
2
Table of Contents
PART I — FINANCIAL INFORMATION
Item 1: Financial Statements
PENFORD CORPORATION AND SUBSIDIARIES
May 31, | August 31, | |||||||
(In thousands, except per share data) | 2005 | 2004 | ||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash | $ | 2,330 | $ | 5,915 | ||||
Trade accounts receivable, net | 35,841 | 38,703 | ||||||
Inventories | 38,872 | 31,807 | ||||||
Prepaid expenses | 3,541 | 4,124 | ||||||
Other | 2,995 | 3,031 | ||||||
Total current assets | 83,579 | 83,580 | ||||||
Property, plant and equipment, net | 127,896 | 130,392 | ||||||
Deferred income taxes | 13,622 | 13,462 | ||||||
Restricted cash value of life insurance | 10,037 | 12,623 | ||||||
Goodwill, net | 21,836 | 20,171 | ||||||
Other intangible assets, net | 2,222 | 2,299 | ||||||
Other assets | 3,059 | 3,269 | ||||||
Total assets | $ | 262,251 | $ | 265,796 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 37,250 | $ | 25,169 | ||||
Accrued pension liability | 1,589 | 3,151 | ||||||
Accrued liabilities | 8,852 | 10,200 | ||||||
Current portion of long-term debt | 5,637 | 4,775 | ||||||
Total current liabilities | 53,328 | 43,295 | ||||||
Long-term debt | 62,421 | 75,551 | ||||||
Other post-retirement benefits | 13,092 | 12,598 | ||||||
Deferred income taxes | 18,997 | 20,809 | ||||||
Other liabilities | 17,632 | 17,824 | ||||||
Total liabilities | 165,470 | 170,077 | ||||||
Shareholders’ equity: | ||||||||
Preferred stock, par value $1.00 per share, authorized 1,000 shares, none issued | — | — | ||||||
Common stock, par value $1.00 per share, authorized 29,000 shares, issued 10,806 and 10,784 shares, respectively | 10,806 | 10,784 | ||||||
Additional paid-in capital | 37,236 | 36,911 | ||||||
Retained earnings | 71,764 | 75,585 | ||||||
Treasury stock, at cost, 1,981 shares | (32,757 | ) | (32,757 | ) | ||||
Accumulated other comprehensive income | 9,732 | 5,196 | ||||||
Total shareholders’ equity | 96,781 | 95,719 | ||||||
Total liabilities and shareholders’ equity | $ | 262,251 | $ | 265,796 | ||||
The accompanying notes are an integral part of these statements.
3
Table of Contents
PENFORD CORPORATION AND SUBSIDIARIES
(Unaudited)
Three months ended | Nine months ended | |||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
(In thousands, except per share data) | 2005 | 2004 | 2005 | 2004 | ||||||||||||
Sales | $ | 76,101 | $ | 72,484 | $ | 217,385 | $ | 207,136 | ||||||||
Cost of sales | 66,061 | 60,461 | 196,956 | 175,393 | ||||||||||||
Gross margin | 10,040 | 12,023 | 20,429 | 31,743 | ||||||||||||
Operating expenses | 6,783 | 6,156 | 18,576 | 17,330 | ||||||||||||
Research and development expenses | 1,447 | 1,595 | 4,290 | 4,551 | ||||||||||||
Restructure costs, net | — | 384 | — | 1,125 | ||||||||||||
Income (loss) from operations | 1,810 | 3,888 | (2,437 | ) | 8,737 | |||||||||||
Non-operating income, net | 1,209 | 505 | 1,661 | 1,010 | ||||||||||||
Interest expense | 1,457 | 1,060 | 4,077 | 3,352 | ||||||||||||
Income (loss) before income taxes | 1,562 | 3,333 | (4,853 | ) | 6,395 | |||||||||||
Income tax expense (benefit) | (1,023 | ) | 1,014 | (2,620 | ) | 2,196 | ||||||||||
Net income (loss) | $ | 2,585 | $ | 2,319 | $ | (2,233 | ) | $ | 4,199 | |||||||
Weighted average common shares and equivalents outstanding: | ||||||||||||||||
Basic | 8,825 | 8,771 | 8,822 | 8,713 | ||||||||||||
Diluted | 8,937 | 8,933 | 8,822 | 8,835 | ||||||||||||
Earnings (loss) per share: | ||||||||||||||||
Basic | $ | 0.29 | $ | 0.26 | $ | (0.25 | ) | $ | 0.48 | |||||||
Diluted | $ | 0.29 | $ | 0.26 | $ | (0.25 | ) | $ | 0.48 | |||||||
Dividends declared per common share | $ | 0.06 | $ | 0.06 | $ | 0.18 | $ | 0.18 |
The accompanying notes are an integral part of these statements.
4
Table of Contents
PENFORD CORPORATION AND SUBSIDIARIES
(Unaudited)
Nine Months Ended | ||||||||
May 31, | May 31, | |||||||
(In thousands) | 2005 | 2004 | ||||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | (2,233 | ) | $ | 4,199 | |||
Adjustments to reconcile net income (loss) to net cash provided by operations: | ||||||||
Depreciation and amortization | 12,992 | 13,374 | ||||||
Deferred income taxes | (2,091 | ) | (753 | ) | ||||
Loss on early extinguishment of debt | — | 665 | ||||||
Gain on sale of investment | (736 | ) | — | |||||
Other | (95 | ) | 1,136 | |||||
Change in assets and liabilities: | ||||||||
Trade accounts receivable | 3,988 | (4,198 | ) | |||||
Prepaid expenses | 641 | 512 | ||||||
Inventories | (5,639 | ) | (3,984 | ) | ||||
Accounts payable and accrued liabilities | 9,985 | 4,002 | ||||||
Taxes payable | (1,650 | ) | 88 | |||||
Other | 111 | 879 | ||||||
Net cash provided by operating activities | 15,273 | 15,920 | ||||||
Cash flows from investing activities: | ||||||||
Investment in property, plant and equipment, net | (6,553 | ) | (8,007 | ) | ||||
Proceeds from investments | 3,525 | — | ||||||
Other | (84 | ) | (210 | ) | ||||
Net cash used in investing activities | (3,112 | ) | (8,217 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from revolving line of credit | 3,000 | 35,975 | ||||||
Payments on revolving line of credit | (13,591 | ) | (65,083 | ) | ||||
Proceeds from long-term debt | — | 50,039 | ||||||
Payments of long-term debt | (3,574 | ) | (24,934 | ) | ||||
Exercise of stock options | 215 | 1,922 | ||||||
Payment of loan fees | (163 | ) | (1,733 | ) | ||||
Payment of dividends | (1,588 | ) | (1,563 | ) | ||||
Net cash used in financing activities | (15,701 | ) | (5,377 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | (45 | ) | (729 | ) | ||||
Net increase (decrease) in cash and cash equivalents | (3,585 | ) | 1,597 | |||||
Cash and cash equivalents, beginning of period | 5,915 | 5,697 | ||||||
Cash and cash equivalents, end of period | $ | 2,330 | $ | 7,294 | ||||
The accompanying notes are an integral part of these statements.
5
Table of Contents
PENFORD CORPORATION AND SUBSIDIARIES
1—BUSINESS
Penford Corporation (“Penford” or the “Company”) is in the business of developing, manufacturing and marketing specialty natural-based ingredient systems for various applications, including papermaking, textiles and food products. The Company operates manufacturing facilities in the United States, Australia, and New Zealand. Penford’s products provide excellent binding and film-forming characteristics that make customers’ products better through natural, convenient and cost effective solutions. Sales of the Company’s products are generated using a combination of direct sales and distributor agreements.
The Company has extensive research and development capabilities, which are used in understanding the complex chemistry of carbohydrate-based materials and their application. In addition, the Company has specialty processing capabilities for a variety of modified starches.
2—BASIS OF PRESENTATION
Consolidation
The accompanying condensed consolidated financial statements include the accounts of Penford and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated. The condensed consolidated balance sheet at May 31, 2005 and the condensed consolidated statements of operations and cash flows for the interim periods ended May 31, 2005 and 2004 have been prepared by the Company without audit. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, that are necessary to present fairly the financial information have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles, have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The results of operations for interim periods are not necessarily indicative of the operating results of a full year or of future operations. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2004.
Recent Accounting Pronouncements
In November 2004, the Financial Accounting Standards Board (“FASB”) issued Statement No. 151, “Inventory Costs—an Amendment of ARB No. 43, Chapter 4” (“SFAS No. 151”). SFAS No. 151, which is effective for inventory costs incurred during years beginning after June 15, 2005, clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material, requiring that those items be recognized as current-period charges. In addition, SFAS No. 151 requires that allocation of fixed production overheads be based on the normal capacity of the production facilities. The adoption of SFAS No. 151 beginning September 1, 2005 is not expected to have a material effect on the Company’s results of operation, financial position or liquidity.
In December 2004, the FASB issued Statement No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123R”). SFAS No. 123R, which is effective for the first interim or annual period beginning after June 15, 2005, requires all share-based payments to employees, including grants of stock options, to be recognized in the financial statements based on their fair values. In addition, two transition alternatives are permitted at the time of adoption of this statement, restating prior year financial statements or recognizing adjustments to share-based liabilities as the cumulative effect of a change in accounting principle. In April 2005, the SEC postponed the effective date of SFAS No. 123R until the issuer’s first fiscal year beginning after June 15, 2005. Under the current rules, the Company will be required to adopt SFAS No. 123R effective September 1, 2005. In March 2005, the SEC issued Staff Accounting Bulletin No. 107 (“SAB 107”) regarding the SEC’s interpretation of SFAS No. 123R. The Company is currently evaluating the requirements of SFAS No. 123R and SAB 107. The Company expects that the adoption of
6
Table of Contents
SFAS No. 123R will have a material effect on its results of operations and earnings per share. The Company has not yet determined the method of adoption or the effect of adopting SFAS No. 123R, and it has not determined whether the adoption will result in amounts that are similar to the current proforma disclosures pursuant to SFAS No. 123.
In March 2005, the FASB issued FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations” (“FIN No. 47”), which requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. FIN No. 47 is effective for fiscal years ending after December 15, 2005. The Company is currently evaluating the effect that the adoption will have on its results of operations and financial position, but does not believe it will have a material impact.
In May 2005, the FASB issued Statement No. 154, “Accounting Changes and Error Corrections” (“SFAS No. 154”), which is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. The Company would be required to adopt SFAS No. 154 in fiscal 2007. SFAS No. 154 provides guidance for and reporting of accounting changes and error corrections. It states that retrospective application, or the latest practicable date, is the required method for reporting a change in accounting principle and the reporting of a correction of an error. The Company is evaluating the effect that the adoption of SFAS No. 154 will have on its results of operations and financial position, but does not believe it will have a material impact.
Stock-based Compensation
The Company accounts for its stock-based employee compensation related to stock options under the intrinsic value recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees” and its various interpretations. Accordingly, no compensation expense has been recognized for the stock-based compensation plans other than for the Directors’ Plan and restricted stock awards.
The following table illustrates the effect on net income and earnings per share if the Company had elected to recognize compensation expense consistent with the provisions prescribed in FASB Statement No. 123, “Accounting for Stock-Based Compensation” (“SFAS No. 123”), as amended. Under SFAS No. 123, compensation expense is measured at the grant date based on the value of the award and is recognized over the vesting period.
Three months ended | Nine months ended | |||||||||||||||
(In thousands, except per share data) | May 31, | May 31, | May 31, | May 31, | ||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
Net income (loss), as reported | $ | 2,585 | $ | 2,319 | $ | (2,233 | ) | $ | 4,199 | |||||||
Add: Stock-based employee compensation expense included in reported net income, net of tax | 35 | 21 | 60 | 58 | ||||||||||||
Less: Stock-based employee compensation expense determined under the fair value method for all awards, net of tax | (153 | ) | (263 | ) | (501 | ) | (953 | ) | ||||||||
Pro forma net income (loss) | $ | 2,467 | $ | 2,077 | $ | (2,674 | ) | $ | 3,304 | |||||||
Earnings (loss) per share: | ||||||||||||||||
Reported basic earnings (loss) per common share | $ | 0.29 | $ | 0.26 | $ | (0.25 | ) | $ | 0.48 | |||||||
Reported diluted earnings (loss) per common share | $ | 0.29 | $ | 0.26 | $ | (0.25 | ) | $ | 0.48 | |||||||
Pro forma basic earnings (loss) per common share | $ | 0.28 | $ | 0.24 | $ | (0.30 | ) | $ | 0.38 | |||||||
Pro forma diluted earnings (loss) per common share | $ | 0.28 | $ | 0.23 | $ | (0.30 | ) | $ | 0.37 | |||||||
7
Table of Contents
3—INVENTORIES
The components of inventory are as follows:
May 31, | August 31, | |||||||
2005 | 2004 | |||||||
(In thousands) | ||||||||
Raw materials | $ | 19,443 | $ | 13,996 | ||||
Work in progress | 681 | 687 | ||||||
Finished goods | 18,748 | 17,124 | ||||||
Total inventories | $ | 38,872 | $ | 31,807 | ||||
4—PROPERTY, PLANT AND EQUIPMENT
May 31, | August 31, | |||||||
2005 | 2004 | |||||||
(In thousands) | ||||||||
Land | $ | 16,820 | $ | 15,952 | ||||
Plant and equipment | 298,364 | 293,721 | ||||||
Construction in progress | 15,203 | 10,526 | ||||||
330,387 | 320,199 | |||||||
Accumulated depreciation | (202,491 | ) | (189,807 | ) | ||||
Net property, plant and equipment | $ | 127,896 | $ | 130,392 | ||||
Changes in Australian and New Zealand currency exchange rates have increased net property, plant and equipment in the first nine months of fiscal 2005 by approximately $3.4 million.
5—DEBT
At May 31, 2005, the Company had $23.5 million outstanding under its revolving credit facilities and $44.5 million in term loans. Effective November 2004, Penford obtained an amendment to the funded debt ratio covenant, a ratio of earnings before interest, depreciation and taxes, as defined, to total debt, in its credit facility agreement. The Company’s lenders agreed to exclude $8.4 million, a majority of the nonrecurring strike-related costs, from the calculation of the funded debt ratio. The agreement was also amended to increase the funded debt ratio threshold to 3.5 for the first half of fiscal 2005, to 3.25 for the third quarter of fiscal 2005, and to 3.0 thereafter. The maximum capital expenditure level was reduced from $20 million to $15 million for fiscal 2005. Pursuant to the terms of the credit agreement, Penford’s borrowing ability was $12.4 million at May 31, 2005. The Company was in compliance as of May 31, 2005 and expects to be in compliance with these revised covenants for the remainder of fiscal 2005.
6—TAXES
The Company’s effective tax rate for the three- and nine-month periods ended May 31, 2005 and 2004 varied from the U.S. federal statutory rate primarily due to U.S. tax credits related to research and development and the favorable tax effect of export sales from the U.S. On a quarterly basis, the Company reviews its estimate of the effective income tax rate expected to be applicable for the full fiscal year. This rate is used to calculate income tax expense or benefit on year-to-date pre-tax income or loss. Income tax expense or benefit for the current interim period is the difference between the computed year-to-date income tax amount and the tax expense or benefit reported for previous quarters. In reviewing its effective tax rate, the Company uses estimates of the amounts of permanent differences between book and tax accounting and projections of fiscal year pre-tax income or loss. Currently, the Company’s best estimate of the annual effective tax rate is 54%. This rate differs from that used in the first half of fiscal 2005 because permanent differences and credits had a greater impact on the tax rate due to changes in projected financial results for the full fiscal year. The tax benefit recognized in the third quarter of fiscal
8
Table of Contents
2005 reflects the Company’s current estimated tax rate applied to year-to-date pre-tax losses, and includes an adjustment increasing its tax benefit related to its first half pre-tax losses by $1.9 million.
7—OTHER COMPREHENSIVE INCOME
The components of total comprehensive income (loss) are as follows:
Three months ended | Nine months ended | |||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Net income (loss) | $ | 2,585 | $ | 2,319 | $ | (2,233 | ) | $ | 4,199 | |||||||
Foreign currency translation adjustments | (1,796 | ) | (4,122 | ) | 4,657 | 4,283 | ||||||||||
Change in unrealized gains on derivative instruments that qualify as cash flow hedges | (137 | ) | 82 | (121 | ) | 823 | ||||||||||
Total comprehensive income (loss) | $ | 652 | $ | (1,721 | ) | $ | 2,303 | $ | 9,305 | |||||||
8—NON-OPERATING INCOME, NET
Non-operating income, net consists of the following:
Three months ended | Nine months ended | |||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Loss on early extinguishment of debt | $ | — | $ | — | $ | — | $ | (665 | ) | |||||||
Gain on sale of investment | 736 | — | 736 | 150 | ||||||||||||
Royalty and licensing income | 436 | 434 | 963 | 1,197 | ||||||||||||
Other | 37 | 71 | (38 | ) | 328 | |||||||||||
Total | $ | 1,209 | $ | 505 | $ | 1,661 | $ | 1,010 | ||||||||
In the third quarter of fiscal 2005, the Company sold a majority of its investment in a small Australian start-up company and recognized a $0.7 million pre-tax gain on the transaction.
In October 2003, Penford refinanced its existing secured credit and inventory financing credit agreements and wrote off the unamortized deferred transaction costs related to these credit agreements. In November 2002, the Company licensed the rights to its resistant starch intellectual property portfolio for applications in human nutrition. The initial licensing fee of $2.25 million received in November 2002 is being amortized over the life of the licensing agreement. In addition, the Company receives royalty income as a percentage of its licensee’s sales of resistant starch for a period of seven years or until a maximum of $11 million in royalties has been received by Penford. The royalty payments are subject to a minimum of $7 million over the first five years of the licensing agreement.
9
Table of Contents
9 – PENSION AND POST-RETIREMENT BENEFIT PLANS
The following represents the net periodic pension and post-retirement benefit costs and related components in accordance with SFAS No. 132 (R) for the three and nine months ended May 31, 2005 and 2004.
Defined benefit pension plans | Three months ended | Nine months ended | ||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Service cost | $ | 266 | $ | 229 | $ | 799 | $ | 686 | ||||||||
Interest cost | 516 | 472 | 1,549 | 1,417 | ||||||||||||
Expected return on plan assets | (467 | ) | (434 | ) | (1,401 | ) | (1,302 | ) | ||||||||
Amortization of transition obligation | — | 30 | — | 90 | ||||||||||||
Amortization of prior service cost | 49 | 27 | 146 | 82 | ||||||||||||
Amortization of actuarial losses | 120 | 110 | 360 | 328 | ||||||||||||
Net periodic benefit cost | $ | 484 | $ | 434 | $ | 1,453 | $ | 1,301 | ||||||||
Post-retirement health care plans | Three months ended | Nine months ended | ||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Service cost | $ | 88 | $ | 126 | $ | 264 | $ | 379 | ||||||||
Interest cost | 194 | 213 | 581 | 639 | ||||||||||||
Amortization of prior service cost | (38 | ) | — | (114 | ) | — | ||||||||||
Amortization of actuarial losses | 9 | 15 | 29 | 44 | ||||||||||||
Net periodic benefit cost | $ | 253 | $ | 354 | $ | 760 | $ | 1,062 | ||||||||
The net post-retirement benefit costs for the three and nine months ended May 31, 2005 declined compared to the same periods last year due to plan changes retroactive to September 1, 2004 pursuant to a new union contract at the Company’s Iowa manufacturing facility.
10
Table of Contents
10—SEGMENT REPORTING
Financial information for the Company’s three segments is presented below. The first two segments, Industrial Ingredients—North America and Food Ingredients—North America, are broad categories of end-market users, primarily served by the Company’s U.S. operations. The third segment is the Company’s geographically separate operations in Australia and New Zealand, which are engaged primarily in the food ingredients business. A fourth item for “corporate and other” activity is presented to provide reconciliation to amounts reported in the condensed consolidated financial statements. Corporate and other represents the activities related to the corporate headquarters such as public company reporting, personnel costs of the executive management team, corporate-wide professional services and elimination and consolidation entries. The elimination of intercompany sales between Australia/New Zealand operations and Food Ingredients—North America of $163,000 and $881,000 for the three and nine month periods ended May 31, 2005, respectively, and $192,000 and $459,000 in the three and nine month periods ended May 31, 2004, respectively, is presented separately since the chief operating decision maker views segment results prior to intercompany eliminations.
Three months ended | Nine months ended | |||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Sales: | ||||||||||||||||
Industrial Ingredients—North America | $ | 38,625 | $ | 38,679 | $ | 109,394 | $ | 107,006 | ||||||||
Food Ingredients—North America | 13,911 | 11,417 | 38,035 | 34,283 | ||||||||||||
Australia/New Zealand operations | 23,728 | 22,580 | 70,837 | 66,306 | ||||||||||||
Intercompany sales | (163 | ) | (192 | ) | (881 | ) | (459 | ) | ||||||||
$ | 76,101 | $ | 72,484 | $ | 217,385 | $ | 207,136 | |||||||||
Income (loss) from operations: | ||||||||||||||||
Industrial Ingredients—North America(1) | $ | 1,842 | $ | 2,964 | $ | (1,944 | ) | $ | 6,079 | |||||||
Food Ingredients—North America | 1,825 | 1,096 | 4,320 | 3,714 | ||||||||||||
Australia/New Zealand operations(2) | (105 | ) | 1,692 | 143 | 3,500 | |||||||||||
Corporate and other | (1,752 | ) | (1,864 | ) | (4,956 | ) | (4,556 | ) | ||||||||
$ | 1,810 | $ | 3,888 | $ | (2,437 | ) | $ | 8,737 | ||||||||
(1) | Restructuring costs of $487,000 have been included in income from operations in the nine month periods ended May 31, 2004. | |
(2) | Restructuring costs of $384,000 and $638,000 have been included in income from operations in the three and nine months ended May 31, 2004, respectively. |
May 31, | August 31, | |||||||
2005 | 2004 | |||||||
(In thousands) | ||||||||
Total assets: | ||||||||
Industrial Ingredients–North America | $ | 97,377 | $ | 101,620 | ||||
Food Ingredients—North America | 32,399 | 32,323 | ||||||
Australia/New Zealand operations | 107,067 | 99,344 | ||||||
Corporate and other | 25,408 | 32,509 | ||||||
$ | 262,251 | $ | 265,796 | |||||
11
Table of Contents
11—EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share reflects only the weighted average common shares outstanding during the period. Diluted earnings (loss) per share reflects weighted average common shares outstanding and the effect of any dilutive common stock equivalent shares.The following table presents the computation of diluted weighted average shares outstanding for the three and nine months ended May 31, 2005 and 2004.
Three months ended | Nine months ended | |||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Weighted average common shares outstanding | 8,825 | 8,771 | 8,822 | 8,713 | ||||||||||||
Net effect of dilutive stock options | 112 | 162 | — | 122 | ||||||||||||
Weighted average common shares, outstanding, assuming dilution | 8,937 | 8,933 | 8,822 | 8,835 | ||||||||||||
Diluted earnings per share is calculated by dividing net income by the average common shares outstanding plus additional common shares that would have been outstanding assuming the exercise of in-the-money stock options, using the treasury stock method. Weighted-average stock options to purchase 372,000 and 1,096,065 common stock for the three and nine months ended May 31, 2005 and 210,000 and 254,820 options to purchase common stock for the three and nine months ended May 31, 2004 were excluded from the calculation of diluted earnings per share because they were antidilutive.
12—LITIGATION
In October 2004, Penford Products Co. (“Penford Products”), a wholly-owned subsidiary of the Company, was served with a lawsuit filed by Graphic Packaging International, Inc. (“Graphic”) in the Fourth Judicial District, Ouachita Parish, State of Louisiana. The petition seeks monetary damages for alleged breach of contract, negligence and tortious misrepresentation. These claims arise out of an alleged agreement obligating Penford Products to supply goods to Graphic and Penford Products’ alleged breach of such agreement, together with conduct related to such alleged breach. Penford has filed an answer generally denying all liability and has countersued for damages. Discovery is proceeding in this case. The Company cannot at this time determine the likelihood of any outcome or estimate damages, if any.
12
Table of Contents
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-looking Statements
The statements contained in this Quarterly Report onForm 10-Q (“Quarterly Report”) that are not historical facts, including, but not limited to statements found in the Notes to Condensed Consolidated Financial Statements and in Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations, are forward-looking statements that represent management’s beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as “believes,” “may,” “will,” “looks,” “should,” “could,” “anticipates,” “expects,” or comparable terminology or by discussions of strategies or trends.
Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly affect expected results. Actual future results could differ materially from those described in such forward-looking statements, and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that could cause actual results to differ materially are the risks and uncertainties discussed in this Quarterly Report, including those referenced above, and those described from time to time in other filings with the Securities and Exchange Commission which include, but are not limited to, competition; the possibility of interruption of business activities due to equipment problems, accidents, strikes, weather or other factors; product development risk; changes in corn and other raw material prices and availability; changes in general economic conditions or developments with respect to specific industries or customers affecting demand for the Company’s products including unfavorable shifts in product mix; unanticipated costs, including labor costs, expenses or third party claims; the risk that results may be affected by construction delays, cost overruns, technical difficulties, nonperformance by contractors or changes in capital improvement project requirements or specifications; interest rate and energy cost volatility; foreign currency exchange rate fluctuations; changes in assumptions used for determining employee benefit expense and obligations; changes in the assumptions used to determine the effective income tax rate; or other unforeseen developments in the industries in which Penford operates.
Results of Operations
Executive Overview
Penford generates revenues, income and cash flows by developing, manufacturing and marketing specialty natural-based ingredient systems for industrial and food applications. The Company develops and manufactures ingredients with starch as a base which provide value-added applications to its customers. Penford’s starch products are manufactured primarily from corn, potatoes, and wheat, and are used as binders and coatings in paper and food production.
In analyzing business trends, management considers a variety of performance and financial measures, including sales revenue growth, sales volume growth, gross margins and operating income of the Company’s business segments. Penford manages its business in three segments. The first two, Industrial Ingredients—North America and Food Ingredients—North America, are broad categories of end-market users, served by operations in the United States. The third segment is the Company’s operations in Australia and New Zealand, which operations are engaged primarily in the food ingredients business.
13
Table of Contents
Consolidated sales for the three months ended May 31, 2005 increased 5% to $76.1 million from $72.5 million in the third quarter of fiscal 2004. Quarterly sales increases were driven by higher volumes in the Food Ingredients—North America and Australian operations, improved pricing in the Industrial Ingredients—North America segment and a stronger Australian dollar. Quarterly gross margin as a percent of sales declined to 13.2% in the third quarter of fiscal 2005 from 16.6% in the same quarter last year due to higher energy, freight and petroleum-based chemical costs in all business segments. Third quarter 2004 operating income included a $0.4 million pre-tax charge related to restructuring costs in the Australian business segment.
Year-to-date sales rose 5% to $217.4 million from $207.1 million last year, reflecting favorable foreign exchange rates, which contributed 2% of the consolidated sales growth, sales volume improvement in the Australia/New Zealand and Food Ingredients—North America business segments, and improved pricing and mix in the North American operations. Operating loss for the nine months ended May 31, 2005 was $2.4 million compared to income of $8.7 million for the same nine-month period last year. Gross margin as a percent of sales declined to 9.4% from 15.3% last year on $4 million of incremental operating costs related to the Cedar Rapids strike which was settled mid-first quarter, higher energy and chemical costs, and higher manufacturing expenses in Australia. Year-to-date operating income for fiscal 2004 included $1.1 million in pre-tax restructuring costs in the Australian and Industrial Ingredients—North America businesses.
Fiscal 2005 third quarter and year-to-date operating expenses increased by $0.6 million and $1.2 million, respectively, primarily due to increases in professional fees associated with the initial attestation on internal controls as required by the Sarbanes-Oxley Act of 2002 and higher employee costs. A discussion of segment results of operations and the effective tax rate follows.
Sales
Fiscal 2005 third quarter sales of $38.6 million at the Industrial Ingredients—North America business unit were comparable to sales in the third quarter of last year. Sales volumes declined 6% due to reduced shipments of lower value-added formulations. The reduction in sales volumes was offset by improvements in product mix and unit pricing in core, international and specialty product categories. Sales of specialty starches rose 10% in the third quarter of fiscal 2005 over the same period last year. Sales for the nine-month period ended May 31, 2005 increased by 2% over the same period in fiscal 2004 to $109.4 million. The favorable effects of product mix, higher average selling prices and a 35% increase in sales of higher margin specialty starches were offset by a 3% year-to-date sales volume decline.
Sales of $23.7 million for the third quarter of fiscal 2005 at the Australia/New Zealand operations rose 5% over the same period of fiscal 2004 on strong foreign currency exchange rates and a sales volume increase of 3%. Third quarter sales in local currency were comparable to the same quarter last year. These positive impacts were offset by competitive pricing pressures from imported products as the Australian dollar continued to appreciate. Fiscal 2005 year-to-date sales of $70.8 million grew 7% over the same period last year. Strong Australian and New Zealand foreign currency exchange rates contributed 6% of the revenue increase, with the remainder attributable to volume growth of 7% offset by unfavorable product mix and continued offshore competition. In local currency, sales rose 2%.
Third quarter fiscal 2005 sales for the Food Ingredients—North America business of $13.9 million expanded $2.5 million, or 22%, compared to the third quarter of last year on volume increases of 21%. Sales of high-margin formulations for the nutrition, or low-carbohydrate, market were strong, accounting for approximately $1.8 million of the sales growth in the third quarter. The Company expects that fourth quarter sales for nutrition food applications will approximate third quarter sales, but that this order level will not be sustained into fiscal 2006. Sales for the nine months ended May 31, 2005 grew $3.8 million, or 11%, to $38.0 million compared to $34.3 million in the same period in fiscal 2004. Volume increases contributed 8% of the sales growth and the remainder is due to favorable product mix. Sales of nutrition applications represented $2.7 million of the nine-month revenue increase.
14
Table of Contents
Income from operations
Income from operations for the third quarter of 2005 at Penford’s Industrial Ingredients—North America business unit declined to $1.8 million from $3.0 million for the prior year quarter. Gross margin as a percent of sales was 13.0% in the quarter ended May 31, 2005 compared to 15.0% for the same period last year. The positive impact of improved unit pricing and sales of higher margin specialty starches was offset by continued high chemical and energy costs, which increased by $2.1 million over the prior year quarter, and by increases in other manufacturing expenses. Losses from operations for the first nine months of fiscal 2005 were $1.9 million compared to income of $6.1 million in fiscal 2004. The primary factors contributing to this decrease were incremental costs of approximately $4 million related to the labor strike at the Company’s Iowa manufacturing facility which ended mid-first quarter of fiscal 2005, and increased energy and chemical costs of $4.5 million. Included in year-to-date fiscal 2004 operating income was a $0.5 million pre-tax charge related to a workforce reduction in this business segment.
Income from operations at the Company’s Australia/New Zealand operations was a loss of $0.1 million for the quarter ended May 31, 2005 compared to income of $1.7 million last year. Third quarter gross margin as a percent of sales decreased from 15.0% last year to 5.1% in the current year quarter. Approximately one-half of the margin decline was attributable to rising costs of oil-based manufacturing inputs, primarily freight, energy and chemicals. The remainder of the decrease is due to lower plant yields and utilization as processes and equipment are being reconfigured to manufacture different product lines. Fiscal 2005 year-to-date operating income decreased by $3.4 million to $0.1 million compared to the prior year period and gross margin as a percent of sales was 5.9% compared to 12.0% last year. The declines in gross margin and operating income for the nine-month period compared to last year are due to the same factors and cost increases as for the third quarter. Included in fiscal 2004 year-to-date operating results was $0.6 million of severance costs related to workforce reductions.
Third quarter 2005 income from operations at the Food Ingredients—North American business unit grew 67% from $1.1 million last year to $1.8 million. Gross margin as a percent of sales improved to 27.4% from 24.8% last year on a quarterly sales volume increase of 21%, higher margins generated by sales of low carbohydrate product applications, and improved plant utilization. Fiscal 2005 year-to-date operating income increased $0.6 million to $4.3 million compared to the same period last year and gross margin as a percent of sales for both nine-month periods was 25.4%.
Corporate operating expenses
Corporate operating expenses for the three months ended May 31, 2005 declined $0.1 million compared to the prior year period as a result of lower overall discretionary spending. Operating expenses for fiscal 2005 year-to-date increased by $0.4 million over the prior year period primarily due to increases in professional fees associated with the initial attestation on internal controls required by the Sarbanes-Oxley Act of 2002.
Interest and taxes
Fiscal 2005 interest expense increased by $0.4 million and $0.7 million, respectively, for the three- and nine-month periods ended May 31, 2005 compared to the same periods last year on higher short-term interest rates in the United States.
The Company’s effective tax rate for the three- and nine-month periods ended May 31, 2005 and 2004 varied from the U.S. federal statutory rate primarily due to U.S. tax credits related to research and development and the favorable tax effect of export sales from the U.S. On a quarterly basis, the Company reviews its estimate of the effective income tax rate expected to be applicable for the full fiscal year. This rate is used to calculate income tax expense or benefit on year-to-date pre-tax income or loss. Income tax expense or benefit for the current interim period is the difference between the computed year-to-date income tax amount and the tax expense or benefit reported for previous quarters. In reviewing its effective tax rate, the Company uses estimates of the amounts of permanent differences between book and tax accounting and projections of fiscal year pre-tax income or loss. Currently, the Company’s best estimate of the annual effective tax rate is 54%. This rate differs from that used in the first half of fiscal 2005 because permanent differences and credits had a greater impact on the tax rate due to changes in projected financial results for the full fiscal year. The tax benefit recognized in the third quarter of fiscal
15
Table of Contents
2005 reflects the Company’s current estimated tax rate applied to year-to-date pre-tax losses, and includes an adjustment increasing its tax benefit related to its first half pre-tax losses by $1.9 million.
Non-operating income, net
Non-operating income, net consists of the following:
Three months ended | Nine months ended | |||||||||||||||
May 31, | May 31, | May 31, | May 31, | |||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
(In thousands) | ||||||||||||||||
Loss on early extinguishment of debt | $ | — | $ | — | $ | — | $ | (665 | ) | |||||||
Gain on sale of investment | 736 | — | 736 | 150 | ||||||||||||
Royalty and licensing income | 436 | 434 | 963 | 1,197 | ||||||||||||
Other | 37 | 71 | (38 | ) | 328 | |||||||||||
Total | $ | 1,209 | $ | 505 | $ | 1,661 | $ | 1,010 | ||||||||
In the third quarter of fiscal 2005, the Company sold a majority of its investment in a small Australian start-up company and recognized a $0.7 million pre-tax gain on the transaction.
In October 2003, Penford refinanced its existing secured credit and inventory financing credit agreements and wrote off the unamortized deferred transaction costs related to these credit agreements. In November 2002, the Company licensed the rights to its resistant starch intellectual property portfolio for applications in human nutrition. The initial licensing fee of $2.25 million received in November 2002 is being amortized over the life of the licensing agreement. In addition, the Company receives royalty income as a percentage of its licensee’s sales of resistant starch for a period of seven years or until a maximum of $11 million in royalties has been received by Penford. The royalty payments are subject to a minimum of $7 million over the first five years of the licensing agreement.
Liquidity and Capital Resources
Penford had working capital of $30.3 million and $40.3 million at May 31, 2005 and August 31, 2004, respectively. Cash flow from operations was $12.0 million and $7.1 million, respectively, for the quarters ended May 31, 2005 and 2004. The increase in operating cash flow was due to the positive impacts of programs to improve assets returns and working capital balances. At May 31, 2005, the Company had $68.0 million outstanding under its revolving credit facilities and term loans, a reduction of $12.3 million since August 31, 2004.
At May 31, 2005, the Company had $23.5 million outstanding under its revolving credit facilities and $44.5 million in term loans. Effective November 2004, Penford obtained an amendment to the funded debt ratio covenant, a ratio of earnings before interest, depreciation and taxes, as defined, to total debt, in its credit facility agreement. The Company’s lenders agreed to exclude $8.4 million, a majority of the nonrecurring strike-related costs, from the calculation of the funded debt ratio. The agreement was also amended to increase the funded debt ratio threshold to 3.50 for the first half of fiscal 2005, to 3.25 for the third quarter of fiscal 2005, and to 3.0 thereafter. The maximum capital expenditure level was reduced from $20 million to $15 million for fiscal 2005. Pursuant to the terms of the credit agreement, Penford’s borrowing ability was $12.4 million at May 31, 2005. The Company was in compliance as of May 31, 2005 and expects to be in compliance with these revised covenants for the remainder of fiscal 2005.
The Company paid dividends of $1.6 million during the nine months ended May 31, 2005, which represents a quarterly rate of $0.06 per share, the same per share dividend rate as the nine months ended May 31, 2004. On June 28, 2005, the Board of Directors declared a dividend of $0.06 per common share payable on September 2, 2005 to shareholders of record as of August 12, 2005. Any future dividends will be paid at the discretion of the Company’s board of directors and will depend upon, among other things, earnings, financial condition, cash requirements and availability, and contractual requirements.
16
Table of Contents
Recent Accounting Pronouncements
In November 2004, the FASB issued Statement No. 151, “Inventory Costs—an Amendment of ARB No. 43, Chapter 4” (“SFAS No. 151”). SFAS No. 151, which is effective for inventory costs incurred during years beginning after June 15, 2005, clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material, requiring that those items be recognized as current-period charges. In addition, SFAS No. 151 requires that allocation of fixed production overheads be based on the normal capacity of the production facilities. The adoption of SFAS No. 151 beginning September 1, 2005 is not expected to have a material effect on the Company’s results of operation, financial position or liquidity.
In December 2004, the FASB issued Statement No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123R”). SFAS No. 123R, which is effective for the first interim or annual period beginning after June 15, 2005, requires all share-based payments to employees, including grants of stock options, to be recognized in the financial statements based on their fair values. In addition, two transition alternatives are permitted at the time of adoption of this statement, restating prior year financial statements or recognizing adjustments to share-based liabilities as the cumulative effect of a change in accounting principle. In April 2005, the SEC postponed the effective date of SFAS No. 123R until the issuer’s first fiscal year beginning after June 15, 2005. Under the current rules, the Company will be required to adopt SFAS No. 123R effective September 1, 2005. In March 2005, the SEC issued Staff Accounting Bulletin No. 107 (“SAB 107”) regarding the SEC’s interpretation of SFAS No. 123R. The Company is currently evaluating the requirements of SFAS No. 123R and SAB 107. The Company expects that the adoption of SFAS No. 123R will have a material effect on its results of operations and earnings per share. The Company has not yet determined the method of adoption or the effect of adopting SFAS No. 123R, and it has not determined whether the adoption will result in amounts that are similar to the current proforma disclosures pursuant to SFAS No. 123.
In March 2005, the FASB issued FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations” (“FIN No. 47”), which requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. FIN No. 47 is effective for fiscal years ending after December 15, 2005. The Company is currently evaluating the effect that the adoption will have on its results of operations and financial position, but does not believe it will have a material impact.
In May 2005, the FASB issued Statement No. 154, “Accounting Changes and Error Corrections” (“SFAS No. 154”), which is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. The Company would be required to adopt SFAS No. 154 in fiscal 2007. SFAS No. 154 provides guidance for and reporting of accounting changes and error corrections. It states that retrospective application, or the latest practicable date, is the required method for reporting a change in accounting principle and the reporting of a correction of an error. The Company is evaluating the effect that the adoption of SFAS No. 154 will have on its results of operations and financial position, but does not believe it will have a material impact.
17
Table of Contents
Risks and Uncertainties
The availability and cost of the agricultural products Penford purchases are vulnerable to weather and other factors beyond its control.
Approximately 30% of Penford’s manufacturing costs are the costs of agricultural raw materials: corn, wheat flour, and potato starch. Weather conditions, plantings and global supply, among other things, have historically caused volatility in the supply and prices of these agricultural products. The Company may not be able to pass through any increases in the cost of agricultural raw materials to its customers. To manage the price volatility in the commodity markets, the Company may purchase inventory in advance or enter into exchange traded futures or options contracts. Despite these hedging activities, Penford may not be successful in limiting its exposure to market fluctuations in the cost of agricultural raw materials. Increases in the cost of corn, wheat flour, and potato starch due to weather conditions or other factors beyond Penford’s control and that cannot be passed through to customers will reduce Penford’s future profitability.
Increases in energy costs will reduce the Company’s profitability.
Electricity and natural gas comprise approximately 15% of the cost of manufacturing the Company’s products in North America. Natural gas is used extensively in the Industrial Ingredients – North America business to dry the starch products. The prices of these inputs to the manufacturing process fluctuate based on anticipated changes in supply and demand, weather and the prices of alternative fuels. Penford may use short-term purchase contracts or exchange traded futures or option contracts to reduce the price volatility of natural gas. Penford may not be able to pass on increases in energy costs to its customers and margins and profitability would be adversely affected.
The loss of a major customer could have an adverse effect on Penford’s results of operations.
None of the Company’s customers constituted 10% of sales in the last three fiscal years. However, in the nine months of fiscal 2005, sales to the top ten customers and sales to the largest customer represented 44% and 9.0%, respectively, of total consolidated net sales. Customers place orders on an as-needed basis and generally can change their suppliers without penalty. If the Company lost one or more of its major customers, or if one or more of its customers significantly reduced its orders, sales and results of operations would be adversely affected.
In order to be successful, Penford must retain and motivate key employees.
In order to be successful, the Company must retain and motivate executives and other key employees. In particular, hiring and retaining qualified personnel in management, research and development, sales and marketing, manufacturing and finance is critical to Penford’s future. Penford faces intense competition for its personnel needs. The loss of key employees could have a significant impact on the Company’s results of operations and stock price.
Changes in interest rates will affect Penford’s profitability.
At May 31, 2005, approximately $58.3 million of the Company’s outstanding debt is subject to variable interest rates which move in direct proportion to the London InterBank Offered Rate (“LIBOR”) or the Australian Bank Bill Buying Rate (BBSY). Significant changes in these interest rates would materially affect Penford’s profitability.
Unanticipated changes in tax rates or exposure to additional income tax liabilities could affect Penford’s profitability.
Penford is subject to income taxes in the United States, Australia and New Zealand. The effective tax rates could be adversely affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities or changes in tax laws. The carrying value of deferred tax assets, which are predominantly in the United States, is dependent on Penford’s ability to generate future taxable income in the United States. The amount of income taxes Penford pays is subject to audit and a material assessment by a governing tax authority could affect profitability.
18
Table of Contents
Profitability is subject to risks associated with changes in foreign exchange currency rates.
In the ordinary course of business, Penford is subject to risks associated with changing foreign exchange rates. For the nine months ended May 31, 2005, approximately 33% of the Company’s revenue is denominated in currencies other than the U.S. dollar. Penford’s revenues and results of operations are affected by fluctuations in exchange rates between the U.S. dollar and the Australian and New Zealand dollars.
Provisions of Washington law could discourage or prevent a potential takeover.
Penford is incorporated in the State of Washington and subject to the anti-takeover provisions of the Washington Business Corporation Act (the “Act”), which prohibits the Company from engaging in a ‘business combination” with an “interested shareholder” for a period of three years after the date of the transaction in which the person became an interested shareholder, unless the business combination is approved in a prescribed manner. The application of the anti-takeover provisions of the Act could have the effect of delaying or preventing a change of control in the ownership of the Company.
Item 3: Quantitative and Qualitative Disclosures About Market Risk.
The Company is exposed to market risks from adverse changes in interest rates, foreign currency exchange rates and commodity prices. Since August 31, 2004, there have been no significant changes in the Company’s exposure to market risks.
Item 4: Controls and Procedures.
Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective such that information related to the Company required to be disclosed in the SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
19
Table of Contents
PART II — OTHER INFORMATION
Item 6: Exhibits.
Exhibits
31.1 | Certifications of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||
31.2 | Certifications of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||
32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
20
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Penford Corporation | ||||
(Registrant) | ||||
July 11, 2005 | /s/ Steven O. Cordier | |||
Steven O. Cordier | ||||
Senior Vice President and Chief Financial Officer |
21
Table of Contents
EXHIBIT INDEX
Exhibit No. | Description | |
31.1 | Certifications of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2 | Certifications of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
22